Effervescent Cold Relief
NDC Package 50201-0246-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Effervescent Cold Relief is uses:temporarily relieves these symptoms of the common cold:- fever - sneezing - nasal congestion - sore throat - headache - minor aches and pains - runny nose - sinus congestion and pressure. Marketed by Tower Laboratories Ltd, this product is identified by NDC 50201-0246 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
50201-0246-1
Package Description
2 TABLET, EFFERVESCENT in 1 POUCH
Product Code
50201-0246
11-Digit Billing Format
50201024601
RxNorm Crosswalk
  • RxCUI: 1536840 - aspirin 325 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
  • RxCUI: 1536840 - ASA 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Effervescent Cold Relief
Dosage Form
-
Usage Information
Uses:temporarily relieves these symptoms of the common cold:- fever - sneezing - nasal congestion - sore throat - headache - minor aches and pains - runny nose - sinus congestion and pressure

Regulatory & Marketing

Labeler Name
Tower Laboratories Ltd
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
07-01-2010
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50201-0246-1 identifies a specific commercial package of 2 tablet, effervescent in 1 pouch of Effervescent Cold Relief, labeled by Tower Laboratories Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tower Laboratories Ltd on July 01, 2010. The current certification is valid through December 31, 2019.

How is this Tower Laboratories Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50201024601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50201-0246-1
11-Digit CMS (5-4-2)
50201-0246-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.